BRCA1 and BRCA2 gene mutations in hereditary and sporadic ovarian cancer and the clinical implications

被引：0

作者：

Farghaly, SA ^{[1
]}

机构：

[1] DHCC, New York, NY 10017 USA

来源：

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 1998年 / 179卷 / 04期

关键词：

D O I：

10.1016/S0002-9378(98)70229-7

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

引用

页码：1101 / 1101

页数：1

共 50 条

[41] Clinical relevance of ten BRCA1 and three BRCA2 intronic germline mutations in families with hereditary breast and/or ovarian cancer [J].

Wappenschmidt, B. ;

Kohler, J. ;

Bosse, K. ;

Versmold, B. ;

Schmutzler, R. K. .

ONKOLOGIE, 2008, 31 :29-29

[42] Clinical implications of genetic testing for BRCA1 and BRCA2 mutations in Austria [J].

Singer, C. F. ;

Muhr, D. ;

Rappaport, C. ;

Tea, M-K ;

Gschwantler-Kaulich, D. ;

Fink-Retter, A. ;

Pfeiler, G. ;

Berger, A. ;

Sun, P. ;

Narod, S. A. .

CLINICAL GENETICS, 2014, 85 (01) :72-75

[43] Etiology of familial breast cancer with undetected BRCA1 and BRCA2 mutations: clinical implications [J].

Eugenia Yiannakopoulou .

Cellular Oncology, 2014, 37 :1-8

[44] Mathematical modeling for prediction of secondary BRCA1 and BRCA2 mutations in ovarian cancers with deleterious germline BRCA1 and BRCA2 mutations [J].

Botesteanu, Dana-Adriana ;

Levy, Doron ;

Lee, Jung-Min .

CANCER RESEARCH, 2016, 76

[45] Etiology of familial breast cancer with undetected BRCA1 and BRCA2 mutations: clinical implications [J].

Yiannakopoulou, Eugenia .

CELLULAR ONCOLOGY, 2014, 37 (01) :1-8

[46] Somatic and germline mutations of the BRCA2 gene in sporadic ovarian cancer [J].

Foster, KA ;

Harrington, P ;

Kerr, J ;

Russell, P ;

DiCioccio, RA ;

Scott, IV ;

Jacobs, I ;

ChenevixTrench, G ;

Ponder, BAJ ;

Gayther, SA .

CANCER RESEARCH, 1996, 56 (16) :3622-3625

[47] BRCA1 and BRCA2 mutations in Germany - indications for testing in hereditary breast and ovarian cancer families. [J].

Schwarz-Boeger, U ;

Schmutzler, RK ;

Bastert, G ;

Bender, HG ;

Beckmann, MW ;

Caffier, H ;

Crohns, C ;

Deininger, J ;

Dietl, J ;

Ditsch, N ;

Distler, W ;

Estevez-Schwarz, L ;

Hepp, H ;

Herroeder, N ;

Huebbel, V ;

Huettner, C ;

Jackisch, C ;

Jonat, W ;

Kandel, M ;

Kast, K ;

Kaufmann, M ;

Krapfl-Gast, AS ;

Kreienberg, R ;

Kuschel, B ;

Luck, H ;

Meindl, A ;

von Minckwitz, G ;

Nestle-Kraemling, C ;

Paepke, S ;

Prieshof, B ;

Rensing, K ;

Rhiem, KA ;

Schaeffer, MA ;

Straub, L ;

Untch, M ;

Kiechle, T .

BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 :S154-S155

[48] A prospective study about BRCA1/BRCA2 germline mutations in hereditary breast/ovarian cancer patients [J].

Ben Kridis, W. ;

Ben Ayed-Guerfali, D. ;

Ammous-Boukhris, N. ;

Ayedi, W. ;

Charfi, S. ;

Boudawara, T. ;

Daoud, J. ;

Khanfir, A. ;

Mokdad-Gargouri, R. .

ANNALS OF ONCOLOGY, 2020, 31 :S1223-S1223

[49] BRCA1- and BRCA2 mutations: Clinical management of patients with hereditary breast and ovarian cancer [J].

Pristauz G. ;

Geigl J.B. ;

Petru E. .

Wiener Medizinische Wochenschrift, 2010, 160 (7-8) :158-162

[50] BRCA1, BRCA2, and hereditary nonpolyposis colorectal cancer gene mutations in an unselected ovarian cancer population: Relationship to family history and implications for genetic testing [J].

Rubin, SC ;

Blackwood, MA ;

Bandera, C ;

Behbakht, K ;

Benjamin, I ;

Rebbeck, TR ;

Boyd, J .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1998, 178 (04) :670-677

← 1 2 3 4 5 →